A LETTER FROM OUR CEO, MILES WRIGHT
It’s an exciting time here at Averix Bio. After many years of planning and months of buildout, we are finally shipping our first products. Proud hardly even comes close to how I feel about our entire team!
Over the past few months, I’ve heard from plenty of people who suggest we’re crazy to launch a large-scale manufacturing business in the middle of a pandemic. Perhaps. There’s no doubt that COVID-19 makes everything harder . . . but I’d also suggest more people than ever are investing time to research their health and wellness products. People want to buy products that are manufactured to the highest standards and provide peace of mind when given to loved ones. Companies want a supplier that can be reliable and drive new products to market. That’s where Averix Bio comes in . . .
Averix Bio is a large-scale producer of cannabinoid-derived products, including broad-spectrum CBD oil, CBD isolate, water-soluble CBD, and other isolated cannabinoid compounds. From Day One we’ve built out and operate our facility to pharma ingredient standards, implementing both cGMP and EU GMP per 21 CFR Parts 210 and 211. We know a little about pharmaceutical manufacturing – we have 175 years of experience in our current staff. From analysis of the starting soil and genetics to final products, we track everything using AI-powered blockchain technology provided by our partner, Rymedi, a pioneer in the health and pharma sectors.
Besides strict compliance, there’s another core trait we strive to inject in all our relationships with vendors, clients, and everyone else – straight talk. We put it on our front door, we put it on our website, we actively discuss in all company meetings: Traceable, Transparent, and Trustworthy. Treat people well and you’ll receive the same.
Give us a call, and let’s talk cannabinoids!
Miles Wright
CEO, Averix Bio
